Literature DB >> 12667816

Intracellular localisation of Fv1.

Melvyn W Yap1, Jonathan P Stoye.   

Abstract

Retroviral resistance mediated by the murine Fv1 gene is believed to result from a direct interaction between the Fv1 gene product and the viral capsid protein. To study the mechanism of Fv1 action, the expression and intracellular localisation of the Fv1 protein were examined. Only very low levels of protein expression seem necessary for virus restriction but the site of expression appears crucial. Active Fv1 was found in association with tubules of the trans-Golgi network, whereas an inactive form was localised in the endoplasmic reticulum. We hypothesize that Fv1 is compartmentalised in the cell on the pathway taken by virus en route to the nucleus, suggesting that incoming virus must pass the trans-Golgi network during its transit to the nucleus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12667816     DOI: 10.1016/s0042-6822(02)00053-3

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

Review 1.  Microtubule Regulation and Function during Virus Infection.

Authors:  Mojgan H Naghavi; Derek Walsh
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

2.  Murine T cells potently restrict human immunodeficiency virus infection.

Authors:  Jörg G Baumann; Derya Unutmaz; Michael D Miller; Sabine K J Breun; Stacy M Grill; Jane Mirro; Dan R Littman; Alan Rein; Vineet N KewalRamani
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

3.  Ordered assembly of murine leukemia virus capsid protein on lipid nanotubes directs specific binding by the restriction factor, Fv1.

Authors:  Laura Hilditch; Rishi Matadeen; David C Goldstone; Peter B Rosenthal; Ian A Taylor; Jonathan P Stoye
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-21       Impact factor: 11.205

4.  Capsid processing requirements for abrogation of Fv1 and Ref1 restriction.

Authors:  Mark P Dodding; Michael Bock; Melvyn W Yap; Jonathan P Stoye
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

5.  Characterization of an amino-terminal dimerization domain from retroviral restriction factor Fv1.

Authors:  Kate N Bishop; Gulnahar B Mortuza; Steven Howell; Melvyn W Yap; Jonathan P Stoye; Ian A Taylor
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

6.  Trim-cyclophilin A fusion proteins can restrict human immunodeficiency virus type 1 infection at two distinct phases in the viral life cycle.

Authors:  Melvyn W Yap; Mark P Dodding; Jonathan P Stoye
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

7.  Murine leukemia viruses: objects and organisms.

Authors:  Alan Rein
Journal:  Adv Virol       Date:  2011-11-15

8.  Role of Human TRIM5α in Intrinsic Immunity.

Authors:  Emi E Nakayama; Tatsuo Shioda
Journal:  Front Microbiol       Date:  2012-03-15       Impact factor: 5.640

Review 9.  Retroviral superinfection resistance.

Authors:  Micha Nethe; Ben Berkhout; Antoinette C van der Kuyl
Journal:  Retrovirology       Date:  2005-08-18       Impact factor: 4.602

10.  Expression levels of Fv1: effects on retroviral restriction specificities.

Authors:  Wilson Li; Melvyn W Yap; Vicky Voss; Jonathan P Stoye
Journal:  Retrovirology       Date:  2016-06-24       Impact factor: 4.602

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.